Lendica and CSG Forte Partnership Ushers in New Era of Embedded Business Lending
BOSTON, Jan. 30, 2024 /PRNewswire/ — Lendica, an embedded AI lending company, and CSG Forte, a CSG® (NASDAQ: CSGS) company and a leader in complete and customizable digital payments, announce a strategic partnership to deliver an embedded business credit solution to small and medium sized US
Domino’s Customers Raise $16 million for St. Jude Children’s Research Hospital®
The record-high fundraising supports The Domino’s Village, a recently opened housing facility at St. Jude ANN ARBOR, Mich., Jan. 30, 2024 /PRNewswire/ — Domino’s customers donated more than $16 million to St. Jude Children’s Research Hospital® in 2023, supporting its work
AlphaGraphics celebrates fifth consecutive year on Entrepreneur’s Franchise 500® list
The franchisor setting the standard for excellence in printing and marketing solutions DENVER, Jan. 30, 2024 /PRNewswire/ — AlphaGraphics, a leading franchisor of printing and marketing solutions, has secured a spot on the prestigious Franchise 500® list of top franchisors in the nation for t
Now Available: Veeva Compass Suite of Commercial Data Products
Complete suite of modern patient, prescriber, and national data products for today’s complex therapies Compass Prescriber includes HCP-level projections for more than 4,000 brands and their prescriptions and procedures PLEASANTON, Calif., Jan. 30, 2024 /PRNewswire/ — Veeva Systems (NYSE
TrusteSolutions Announces 2023 Growth in Chapter 7 Case Management Market and 100% Satisfaction Ratings for Software and Support
HOUSTON, Jan. 30, 2024 /PRNewswire/ — TrusteSolutions (TES), the technology innovator of the most advanced case management platform in the enterprise-level, cloud-based case management software industry for the bankruptcy and receivership market, shared its steady growth numbers in 2023 with f
Superior HealthPlan Celebrates 25 Years of Putting Members First
With more than 2 million members, Superior has grown into the largest Medicaid managed care organization in Texas. AUSTIN, Texas, Jan. 30, 2024 /PRNewswire/ — Superior HealthPlan (“Superior”), the leading managed care organization in the state of Texas and a wholly owned subsidi
Shutterstock Increases Quarterly Dividend By 11% to $0.30
New York, Jan. 30, 2024 /PRNewswire/ — Shutterstock, Inc. (NYSE: SSTK), a leading global creative platform connecting brands and businesses to high-quality content, today announced that its Board of Directors has declared a cash dividend of $0.30 per share of outstanding common stock on Janua
XTANDI® (enzalutamide) Receives Health Canada Approval as the First and Only Treatment for High-Risk Patients with Non-Metastatic Castration-Sensitive Prostate Cancer (nmCSPC)
MARKHAM, ON, Jan. 30, 2024 /CNW/ – Today, Astellas Pharma Canada, Inc. announced that Health Canada has approved a supplemental New Drug Application for XTANDI® (enzalutamide) in a new prostate cancer treatment setting. With this approval, XTANDI becomes the first and only androgen receptor
DoorDash Will DoorDash Stuff From All the Big Game Ads to One Lucky Viewer
Win all the snacks, every vehicle, and, honestly, who knows what else from every commercial that airs during the broadcast in the most expansive Big Game giveaway ever Head to www.doordash-all-the-ads.com to learn more SAN FRANCISCO, Jan. 30, 2024 /PRNewswire/ — Today, DoorDash (NASDAQ: DASH),
FDA Grants Orphan Drug Designation (ODD) Status to NeoImmuneTech’s NT-I7 for Advanced Pancreatic Cancer Treatment
Pancreatic cancer has the highest mortality rate of all major cancers with only a 3% relative-survival-rate at 5-years for the advanced form. [1], [2] Pancreatic tumors are highly resistant to chemotherapy and radiation and there are limited treatment options[2] FDA ODD designation bolsters NeoImmu
